Term: Generic Substitution Policies
Last Updated: 2005-11-30
Pharmaceutical policies that use utilization management techniques aimed at providing patients (and, to a more limited extent, providers) the financial incentive to consider the relative costs and benefits of competing, therapeutically equivalent products.